Next to production techniques, multiple usage and product aging were identified as impact factors for nanoparticle release.
Accumulating evidence has demonstrated a pathogenic role of advanced glycation end products (AGEs) and receptors for AGEs (RAGE) in inflammation.
Serum AGE levels were measured using OxiSelect™ Advanced Glycation End Product (AGE) ELISA Kit.
On one hand, product age could be informative about the degree of obsolescence of the product.
Major adducts indicative of protein damage include the advanced glycation end product (AGE) carboxymethyllysine (CML) and argpyrimidine protein adducts.
Rat Glycated Haemoglobin A1c (GHbA1c) ELISA Kit was purchased from CUSABIO® (Wuhan, China) while OxiSelect™ Advanced Glycation End Product (AGE) ELISA Kit was acquired from Cell Biolabs (Selangor, Malaysia).
Oxidative stress increases advanced glycation end product (AGE) accumulation and activation of Protein kinase C and the polyol pathway [12, 13].
The association to product age and the inclusion of any actual cost was due to the correlation of funding and product age.
Inclusion of healthcare costs did not vary by journal, primary author's country, study location, product age or conclusion.
Journal, study conclusions, study location, primary author's country and product age were not associated with inclusion of cost information.
